MA43791A - Composés de carbapénème - Google Patents
Composés de carbapénèmeInfo
- Publication number
- MA43791A MA43791A MA043791A MA43791A MA43791A MA 43791 A MA43791 A MA 43791A MA 043791 A MA043791 A MA 043791A MA 43791 A MA43791 A MA 43791A MA 43791 A MA43791 A MA 43791A
- Authority
- MA
- Morocco
- Prior art keywords
- carbapenem compounds
- carbapenem
- compounds
- Prior art date
Links
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical class C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201641009127 | 2016-03-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA43791A true MA43791A (fr) | 2018-11-28 |
Family
ID=58715155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA043791A MA43791A (fr) | 2016-03-16 | 2017-03-15 | Composés de carbapénème |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11180504B2 (fr) |
| EP (1) | EP3430013B1 (fr) |
| JP (1) | JP7213173B2 (fr) |
| KR (1) | KR102435777B1 (fr) |
| CN (1) | CN109415365B (fr) |
| AU (1) | AU2017235293B2 (fr) |
| CA (1) | CA3015309C (fr) |
| IL (1) | IL261782B2 (fr) |
| MA (1) | MA43791A (fr) |
| MX (1) | MX382439B (fr) |
| WO (1) | WO2017158616A1 (fr) |
| ZA (1) | ZA201805158B (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020027553A1 (fr) * | 2018-08-03 | 2020-02-06 | 한양대학교 에리카산학협력단 | Sonde pour la détection de bactéries résistantes au carbapénème et utilisation correspondante |
| KR102288736B1 (ko) | 2018-08-03 | 2021-08-12 | 한양대학교 에리카산학협력단 | 카바페넴 내성 박테리아 검출용 프로브 및 이의 용도 |
| EP4377321A1 (fr) * | 2021-07-28 | 2024-06-05 | University of KwaZulu-Natal | Inhibiteurs de métallo-?-lactamases |
| EP4538264A1 (fr) | 2022-06-13 | 2025-04-16 | Alivexis, Inc. | Composé d'amine cyclique d'azacycloalkyle carbonyle |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4194047A (en) | 1975-11-21 | 1980-03-18 | Merck & Co., Inc. | Substituted N-methylene derivatives of thienamycin |
| EP0017992A1 (fr) | 1979-04-19 | 1980-10-29 | Merck & Co. Inc. | Acides 1-carbadéthiapén-2-èm-carboxyliques substitués en position 2 et 6, procédés pour les préparer, compositions pharmaceutiques antibiotiques les contenant et procédé pour préparer des intermédiaires |
| EP0044170A1 (fr) | 1980-07-11 | 1982-01-20 | Beecham Group Plc | Antibiotiques bêta-lactame, leur préparation et leur utilisation |
| JPS57158785A (en) | 1981-02-27 | 1982-09-30 | Beecham Group Ltd | Beta-lactam antibiotic, manufacture and medicinal composition |
| EP0059554A3 (fr) | 1981-02-27 | 1982-10-20 | Beecham Group Plc | Antibiotiques bêta-lactame, un procédé pour leur préparation et leur application en compositions pharmaceutiques |
| CA1283906C (fr) | 1983-05-09 | 1991-05-07 | Makoto Sunagawa | COMPOSE DE .beta.-LACTAM ET PROCEDE DE PRODUCTION |
| JPS60233076A (ja) * | 1984-05-03 | 1985-11-19 | Sumitomo Chem Co Ltd | 新規なβ−ラクタム化合物およびその製造法 |
| JPS6383062A (ja) * | 1986-09-26 | 1988-04-13 | Nippon Redarii Kk | アゼチジンスルホン酸誘導体 |
| CA2004798A1 (fr) * | 1988-12-09 | 1990-06-09 | Jacques Banville | 6-aminoalkyl carbapenemes |
| JPH04211083A (ja) * | 1990-02-23 | 1992-08-03 | Sankyo Co Ltd | カルバペネム−３−カルボン酸誘導体 |
| JP2934283B2 (ja) * | 1990-05-29 | 1999-08-16 | 第一製薬株式会社 | カルバペネム誘導体 |
| AU651887B2 (en) | 1991-06-04 | 1994-08-04 | Sankyo Company Limited | 1-methylcarbapenem derivatives, their preparation and their use as antibiotics |
| US5317016A (en) * | 1991-08-20 | 1994-05-31 | Shionogi Seiyaku Kabushiki Kaisha | Pyrrolidylthiocarbapenem derivative |
| GB9202298D0 (en) * | 1992-02-04 | 1992-03-18 | Ici Plc | Antibiotic compounds |
| JP3411589B2 (ja) * | 1992-05-11 | 2003-06-03 | 第一製薬株式会社 | カルバペネム誘導体 |
| US5602118A (en) | 1993-03-16 | 1997-02-11 | American Cyanamid Company | 2-thiosubstituted carbapenems |
| JP3199300B2 (ja) | 1994-05-09 | 2001-08-13 | 三共株式会社 | １−メチルカルバペネム誘導体 |
-
2017
- 2017-03-15 EP EP17724297.1A patent/EP3430013B1/fr active Active
- 2017-03-15 IL IL261782A patent/IL261782B2/en unknown
- 2017-03-15 WO PCT/IN2017/000060 patent/WO2017158616A1/fr not_active Ceased
- 2017-03-15 MA MA043791A patent/MA43791A/fr unknown
- 2017-03-15 KR KR1020187029573A patent/KR102435777B1/ko active Active
- 2017-03-15 AU AU2017235293A patent/AU2017235293B2/en active Active
- 2017-03-15 CA CA3015309A patent/CA3015309C/fr active Active
- 2017-03-15 MX MX2018011095A patent/MX382439B/es unknown
- 2017-03-15 JP JP2019500051A patent/JP7213173B2/ja active Active
- 2017-03-15 CN CN201780017093.0A patent/CN109415365B/zh active Active
- 2017-03-15 US US16/083,980 patent/US11180504B2/en active Active
-
2018
- 2018-07-31 ZA ZA2018/05158A patent/ZA201805158B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL261782B2 (en) | 2024-07-01 |
| CA3015309C (fr) | 2024-02-13 |
| AU2017235293B2 (en) | 2021-02-04 |
| CA3015309A1 (fr) | 2017-09-21 |
| EP3430013B1 (fr) | 2023-11-15 |
| BR112018068462A2 (pt) | 2019-01-22 |
| AU2017235293A1 (en) | 2018-08-23 |
| US20200291029A1 (en) | 2020-09-17 |
| KR102435777B1 (ko) | 2022-08-23 |
| KR20180133420A (ko) | 2018-12-14 |
| WO2017158616A8 (fr) | 2018-06-07 |
| RU2018136064A (ru) | 2020-04-16 |
| MX382439B (es) | 2025-03-13 |
| CN109415365A (zh) | 2019-03-01 |
| US11180504B2 (en) | 2021-11-23 |
| JP7213173B2 (ja) | 2023-01-26 |
| EP3430013A1 (fr) | 2019-01-23 |
| WO2017158616A1 (fr) | 2017-09-21 |
| IL261782B1 (en) | 2024-03-01 |
| ZA201805158B (en) | 2023-01-25 |
| RU2018136064A3 (fr) | 2020-04-16 |
| JP2019512547A (ja) | 2019-05-16 |
| MX2018011095A (es) | 2019-01-10 |
| CN109415365B (zh) | 2022-08-09 |
| IL261782A (en) | 2018-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3691623A4 (fr) | Composés de benzosulfonyle | |
| EP3720430A4 (fr) | Composés benzocarbonyle | |
| MA42293A (fr) | Composés antibactériens | |
| EP3558322A4 (fr) | Composés benzyl-amide phosphodiamide antiviraux | |
| EP3532069A4 (fr) | Composés aryl-amide phosphodiamide antiviraux | |
| IL264458B (en) | Cannabis composition | |
| EP3474845A4 (fr) | Composés immunomodulateurs | |
| MA46242A (fr) | Composés inhibiteurs de bêta-lactamase | |
| ME03419B (fr) | Composés dihydroisoquinolinone substitués | |
| MA41614A (fr) | Composés antiviraux | |
| EP3445750A4 (fr) | Composés thérapeutiques | |
| EP3609871A4 (fr) | Composés d'amide aryl cyclopropyl-amino-isoquinolinyl | |
| MA50504A (fr) | Composés antibactériens | |
| LT3468975T (lt) | Nauji antibakteriniai junginiai | |
| PT4039675T (pt) | Compostos de fenil-2-hidroxi-acetilamino-2-metil-fenilo | |
| EP3464336A4 (fr) | Composés | |
| EP3436003A4 (fr) | Composés bicycliques antidiabétiques | |
| EP3728289A4 (fr) | Composés optimisés | |
| MA43799A (fr) | Composés de 2-oxindole | |
| EP3310352A4 (fr) | Composés cristallins | |
| MA51221A (fr) | Composés de pyrazolopyridinone | |
| EP3713941A4 (fr) | Composés de pyrazolopyridinone | |
| EP3259254A4 (fr) | Composés thérapeutiques | |
| MA49885A (fr) | Composés macrocycliques | |
| EP3504269A4 (fr) | Composés de fluoroélastomère |